Hershey Trust CO Magenta Therapeutics, Inc. Transaction History

Hershey Trust CO

  • $396 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$4.43 - $8.33 $89,884 - $169,015
-20,290 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$6.07 - $9.89 $123,160 - $200,668
20,290 New
20,290 $148,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Hershey Trust CO Portfolio

Follow Hershey Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hershey Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email